{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:53:18Z","timestamp":1780379598973,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jinf.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T03:33:24Z","timestamp":1528256004000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014"],"prefix":"10.1016","volume":"77","author":[{"given":"Winfried V.","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Dettenkofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"G\u00f6tting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas F.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9202","authenticated-orcid":false,"given":"Christian","family":"Theilacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2018.05.004_bib0001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2018.05.004_bib0002","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th european conference on infections in leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jinf.2018.05.004_bib0003","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2018.05.004_bib0004","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jinf.2018.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 5","key":"10.1016\/j.jinf.2018.05.004_bib0006","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant gram-negative bacterial infections in patients with cancer","volume":"59","author":"Perez","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.05.004_bib0007","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.05.004_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"issue":"45","key":"10.1016\/j.jinf.2018.05.004_bib0009","doi-asserted-by":"crossref","first-page":"e1931","DOI":"10.1097\/MD.0000000000001931","article-title":"Prevalence of resistant gram-negative bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: a single center retrospective cohort study","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jinf.2018.05.004_bib0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.20411\/pai.v1i2.115","article-title":"Increasing rates of fluoroquinolone resistance in escherichia coli isolated from the blood and urine of patients with hematologic malignancies and stem cell transplant recipients","volume":"1","author":"Hauck","year":"2016","journal-title":"Pathog Immun"},{"issue":"5","key":"10.1016\/j.jinf.2018.05.004_bib0011","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2018.05.004_bib0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.jinf.2018.05.004_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4065\/mcp.2010.0006","article-title":"Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline","volume":"85","author":"Therriault","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.jinf.2018.05.004_bib0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/bmt.2010.286","article-title":"Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients","volume":"46","author":"Liu","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jinf.2018.05.004_bib0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cmi.2017.03.020","article-title":"Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS)","volume":"23","author":"Weisser","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jinf.2018.05.004_bib0016","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/428046","article-title":"Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project","volume":"40","author":"Dettenkofer","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2018.05.004_bib0017","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bmt.1703920","article-title":"Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation","volume":"31","author":"Dettenkofer","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jinf.2018.05.004_bib0018","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.jinf.2018.05.004_bib0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/646750","article-title":"Nosocomial infections in neutropenic cancer patients","volume":"14","author":"Carlisle","year":"1993","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2018.05.004_bib0020","doi-asserted-by":"crossref","first-page":"g5060","DOI":"10.1136\/bmj.g5060","article-title":"Interpreting and comparing risks in the presence of competing events","volume":"349","author":"Wolkewitz","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2018.05.004_bib0021","series-title":"Competing risks and multistate models with R","author":"Beyersmann","year":"2011"},{"issue":"446","key":"10.1016\/j.jinf.2018.05.004_bib0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"10.1016\/j.jinf.2018.05.004_bib0023","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbmt.2008.08.008","article-title":"Variation in supportive care practices in hematopoietic cell transplantation","volume":"14","author":"Lee","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2018.05.004_bib0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.hemonc.2013.04.001","article-title":"Hematopoietic stem cell transplantation practice variation among centers in the Eastern mediterranean region (EMRO): eastern mediterranean bone marrow transplantation (EMBMT) group survey","volume":"6","author":"Rasheed","year":"2013","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4","key":"10.1016\/j.jinf.2018.05.004_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/tid.12237","article-title":"Antimicrobial prophylaxis in hematopoietic stem cell transplantation recipients: 10 years after","volume":"16","author":"Trifilio","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2018.05.004_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cncr.11044","article-title":"Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli","volume":"97","author":"Gomez","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jinf.2018.05.004_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-005-1278-x","article-title":"Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia","volume":"24","author":"Kern","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2018.05.004_bib0028","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/428732","article-title":"Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies","volume":"40","author":"Reuter","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2018.05.004_bib0029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10096-007-0428-8","article-title":"Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit","volume":"27","author":"Saito","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2018.05.004_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/dkh510","article-title":"Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002","volume":"55","author":"Kern","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2018.05.004_bib0031","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/ejh.12345","article-title":"Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia","volume":"93","author":"Verlinden","year":"2014","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jinf.2018.05.004_bib0032","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.jinf.2018.05.004_bib0033","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"issue":"30","key":"10.1016\/j.jinf.2018.05.004_bib0034","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1200\/JCO.2006.08.7395","article-title":"Rational selection of patients for antibacterial prophylaxis after chemotherapy","volume":"25","author":"Cullen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jinf.2018.05.004_bib0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/1471-2334-13-563","article-title":"Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis","volume":"13","author":"De Rosa FG","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2018.05.004_bib0036","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-010-0984-1","article-title":"Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters","volume":"29","author":"Syrjala","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:21Z","timestamp":1759008381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318301567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0163445318301567"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.05.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}